Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
Clinical trial NCT02536859 · COMPLETED
Trial details
- NCT number
- NCT02536859
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2016-04-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.